1. OUDIZ, RJ. Ambrisentan therapy in patients with pulmonary arterial hypertension: 3-years outcome. Chest, 140: 3-7, 2011.
2. D’ALONZO, DE. et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med, 115: 343-349, 1991.